Skip to content

Application of immune cell detection in disease prediction and therapeutic drug selection in patients with primary immune thrombocytopenia

Application of immune cell detection in disease prediction and therapeutic drug selection in patients with primary immune thrombocytopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060164
Enrollment
Unknown
Registered
2022-05-21
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary immune thrombocytopenia (ITP)

Interventions

Gold Standard:Clinical outcome
Index test:Immunocell detection

Sponsors

Anhui Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The diagnosis of ITP is consistent with the diagnostic criteria of the Chinese Expert Consensus on the Diagnosis and Treatment of Adult Primary Immune Thrombocytopenia (2020 Edition); 2. The patient has no mental disease; 3. Patients were informed of the study and signed informed consent; 4. The control group was normal immune function patients without serious infection and autoimmune disease.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating; 2. Patients with history of thrombosis; 3. Patients with severe heart, lung, liver and kidney insufficiency; 4. Uncontrollable hypertension, hyperglycemia, peptic ulcer, etc.; 5. Severe or difficult to control infections: such as viral infections (HIV, HBV, HCV, herpes virus, etc.), fungi, tuberculosis, etc.; 6. Patients with a history of mental illness; 7. Other secondary thrombocytopenia: such as autoimmune diseases, thyroid diseases, lymphatic system proliferative diseases, myelodysplastic disorders (aplastic anemia, myelodysplastic syndrome, myelofibrosis, etc.), hematologic malignancies.

Design outcomes

Primary

MeasureTime frame
immunocytoassay;

Countries

China

Contacts

Public ContactZhou Li

Anhui Provincial Hospital

zhouli-324@1603.com+86 17756071226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026